Randomized, Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen, Combined With ASA During the First Month, Versus ASA Alone for the Acute Treatment of High-risk Patients With Acute Non-disabling Cerebrovascular Event (TIA or Minor Stroke)

Trial Profile

Randomized, Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen, Combined With ASA During the First Month, Versus ASA Alone for the Acute Treatment of High-risk Patients With Acute Non-disabling Cerebrovascular Event (TIA or Minor Stroke)

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Oct 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke; Transient ischaemic attacks
  • Focus Therapeutic Use
  • Acronyms CASTIA; CHANCE
  • Sponsors Sanofi
  • Most Recent Events

    • 19 Oct 2017 Results of study (n=3026) assessing association between stress hyperglycemia and risk of new stroke published in the Stroke.
    • 19 Apr 2017 Results of a post-hoc analysis investigating the short-term time course risks and benefits of clopidogrel with aspiriin minor ischemic stroke or TIA, published in the Neurology.
    • 01 Nov 2016 Results of a substudy published in the Stroke.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top